ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01435343
Recruitment Status : Completed
First Posted : September 16, 2011
Last Update Posted : April 25, 2017
Sponsor:
Information provided by (Responsible Party):
PETHEMA Foundation